Colgate‑Palmolive Company reported first‑quarter 2026 results that included net sales of $5.32 billion, an 8.4% year‑over‑year increase from $4.911 billion in Q1 2025. GAAP earnings per share fell to $0.80 from $0.85, while base‑business EPS rose to $0.97 from $0.91, beating the consensus estimate of $0.94. Gross profit margin contracted to 60.6% from 60.8% in the prior year, and operating profit on a base‑business basis grew 4%. Free cash flow increased 28% year‑to‑date to $0.61 billion.
The revenue growth was driven by stronger demand in the Oral Care and Personal Care segments, particularly in emerging markets, offset by a modest decline in the Home Care segment. The company’s exit from the private‑label pet‑food business contributed a 0.6% negative impact on revenue, while the expansion of Hill’s Pet Nutrition continued to support growth in the Pet Nutrition segment. The mix shift toward higher‑margin categories helped mitigate some of the cost pressures.
Base‑business EPS beat expectations by $0.03, largely due to disciplined cost management and a favorable product mix. The GAAP EPS miss was attributable to restructuring charges associated with the Strategic Growth and Productivity Program, which are expected to generate $200‑$300 million in annualized savings but require upfront costs of $350‑$550 million. The program’s impact is reflected in the current quarter’s earnings but is expected to improve profitability over the long term.
Gross margin compression was driven by higher raw‑material and packaging costs, exacerbated by geopolitical tensions that increased logistics expenses. Management revised its full‑year gross‑margin outlook to be down, reversing the previous expectation of an increase. This adjustment signals caution amid persistent cost inflation and trade‑policy headwinds, while still maintaining confidence in the company’s pricing power and operational leverage.
The company reiterated its 1%‑4% organic sales growth guidance for 2026 and reaffirmed its 2030 strategy, emphasizing continued investment in innovation and market expansion. Management highlighted the importance of the Hill’s Pet Nutrition segment and the Strategic Growth and Productivity Program as key drivers of future growth. "On both a GAAP and Base Business basis we have maintained our full-year guidance for net and organic sales growth and earnings per share, but we now expect gross profit margin to be down year over year, versus up year over year previously," said Noel Wallace, Chairman, CEO & President. "We are pleased to have accelerated our net and organic sales growth momentum in the first quarter of 2026 in the face of significant geopolitical and macroeconomic volatility."
The results underscore Colgate‑Palmolive’s ability to navigate a challenging operating environment while sustaining underlying business strength. The company’s focus on cost discipline, strategic investments, and emerging‑market expansion positions it to maintain competitive advantage and deliver long‑term shareholder value.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.